Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients

被引:2
|
作者
Stanciu, Adina Elena [1 ]
Zamfir-Chiru-Anton, Adina [2 ]
Stanciu, Marcel Marian [3 ]
Gherghe, Mirela [4 ,5 ]
Hainarosie, Razvan [6 ,7 ]
Furtunescu, Florentina Ligia [8 ]
Gheorghe, Dan Cristian [7 ,9 ]
机构
[1] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Carcinogenesis & Mol Biol, 252 Fundeni St, Bucharest 022328, Romania
[2] Grigore Alexandrescu Childrens Emergency Hosp, ENT Dept, Bucharest 011743, Romania
[3] Politehn Univ, Elect Engn Fac, Bucharest 060042, Romania
[4] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Nucl Med, Bucharest 022328, Romania
[5] Carol Davila Univ Med & Pharm, Dept Radiol, Bucharest 050463, Romania
[6] Prof Dr Dorin Hociota Inst Phonoaudiol & Funct EN, ENT Dept, Bucharest 050751, Romania
[7] Carol Davila Univ Med & Pharm, ENT Dept, Bucharest 050463, Romania
[8] Carol Davila Univ Med & Pharm, Dept Complementary Sci, 37 Dionisie Lupu St, Bucharest 050463, Romania
[9] Maria Sklodowska Curie Childrens Emergency Hosp, ENT Dept, Bucharest 077120, Romania
关键词
burn injury; biomarkers; MMP-9; TIMP-1; ratio; THERMAL-INJURY; SKIN; HYPERPERMEABILITY; MELATONIN; SEVERITY; MMP-9;
D O I
10.3892/etm.2021.10496
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Burn injuries can trigger tissue changes that can explain the variation in the level of different biochemical markers that can be recorded both locally or systemically. Some events observed in burn wounds such as vascular hyperpermeability have been associated with the release of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) after trauma. Because it is unknown whether the serum levels of MMP-9 and TIMP-1 are a consequence of these destructions or a local response to thermal damage, we decided to follow their dynamics. Twenty-five patients (mean age 49.40 +/- 17.55 years) with a total body surface area (TBSA) affected by a thermal burn of <25% and 30 healthy subjects (mean age 49.70 +/- 8.04 years) were enrolled in the present study. Enzyme immunoassays were used to measure the serum levels of MMP-9 and TIMP-1. Our results showed that MMP-9 was increased 6.25-fold immediately after injury compared to the controls and remained on a plateau throughout the 7-day monitoring period. TIMP-1 showed an upward trend with an increase of 49.52% on the seventh day after triggering insult. The time-course of the MMP-9/TIMP-1 ratio followed the inverse dynamics of TIMP-1 starting from a ratio value measured at admission 3.82-fold higher than the one observed in the healthy volunteers and a highly statistically significant correlation between the values measured at different time-points during the monitoring period (P<0.001). The results of this retrospective study indicate that the MMP-9/TIMP-1 ratio may provide information on local changes over time, starting from the triggering insult, and may be considered as a predictive biomarker of burn evolutivity.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Serum matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 and left venricle performance in patients with aortic stenosis
    Goncharova, N.
    Moiseeva, O.
    Aleshina, G.
    Shlykhto, E.
    CIRCULATION, 2008, 118 (12) : E248 - E248
  • [32] Matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 release from human neutrophils
    Gillespie, AS
    Elliott, E
    FEBS JOURNAL, 2005, 272 : 141 - 142
  • [33] Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases
    Fireman, E
    Kraiem, Z
    Sade, O
    Greif, J
    Fireman, Z
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (02): : 331 - 337
  • [34] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure - Reply
    Fonarow, Gregg C.
    Horwich, Tamara B.
    Eshaghian, Shervin
    AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [35] Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma
    Tanaka, H
    Miyazaki, N
    Oashi, K
    Tanaka, S
    Ohmichi, M
    Abe, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) : 900 - 905
  • [36] Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor
    Locksmith, GJ
    Clark, P
    Duff, P
    Saade, GR
    Schultz, GS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (02) : 159 - 164
  • [37] Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
    Madjid, Tita Husnitawati
    Ardiansyah, Dennis Fachmi
    Permadi, Wiryawan
    Hernowo, Bethy
    DIAGNOSTICS, 2020, 10 (06)
  • [38] Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio
    Doherty, GM
    Kamath, SV
    de Courcey, F
    Christie, SN
    Chisakuta, A
    Lyons, JD
    Heaney, LG
    Ennis, M
    Shields, MD
    CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (09): : 1168 - 1174
  • [39] URINARY MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR MATRIX METALLOPROTEINASE-1 IN CHILDREN WITH URETEROPELVIC JUNCTION OBSTRUCTION
    Li, Zhenzhen
    Wen, Jianguo
    Shi, Hufeng
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 537 - 537
  • [40] Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
    Guzel, Savas
    Serin, Ozden
    Guzel, Eda Celik
    Buyuk, Banu
    Yilmaz, Guzin
    Guvenen, Guvenc
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2013, 28 (02): : 165 - 173